or Try an Advanced Search...

    Diabetes Care Stocks List

    Symbol Grade Name % Change
    TNDM D Tandem Diabetes Care, Inc. 0.24
    NVO F Novo Nordisk A/S -1.30
    PRGO F Perrigo Company -1.49
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Diabetes Endocrine System Hormones Insulin Pharmaceutical Products Pharmaceuticals Segment Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Caregiver Cough Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dietary Supplement Endocrinology Feminine Hygiene

    Related ETFs - A few ETFs which own one or more of the above listed Diabetes Care stocks.

    Symbol Grade Name Weight
    EDEN D iShares MSCI Denmark Capped ETF 22.75
    OZEM D Roundhill GLP-1 & Weight Loss ETF 20.43
    THNR D Amplify Weight Loss Drug & Treatment ETF 12.82
    PPH D Market Vectors Pharmaceutical ETF 9.09
    IGTR C Innovator Gradient Tactical Rotation Strategy ETF 8.81
    View all Diabetes Care ETFs...
    Compare ETFs
    Compare EDEN to THNR Compare OZEM to THNR Compare THNR to IGTR

        Diabetes Care Stocks Recent News

        Date Stock Title
        Oct 2 TNDM Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
        Oct 2 TNDM Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says
        Oct 2 NVO European Equities Close Mostly Higher in Wednesday Trading; Euro Area Unemployment Unchanged in August
        Oct 2 NVO Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
        Oct 2 NVO Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn’t a Problem.
        Oct 2 NVO Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
        Oct 2 TNDM This pharma stock offers an attractive risk-reward says RBC
        Oct 2 NVO Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
        Oct 2 NVO Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
        Oct 1 NVO Novo Nordisk (NVO) Stock Moves -0.89%: What You Should Know
        Oct 1 TNDM BDX upped to buy by Citi, TNDM put on Negative Catalyst Watch
        Oct 1 TNDM Why Tandem Diabetes Care Stock Took It on the Chin Tuesday
        Oct 1 NVO U.S. port strike expected to have limited impact on healthcare supply chain: HHS
        Oct 1 NVO Novo Nordisk has mitigation plans to minimize disruption from port strikes, CNBC reports
        Oct 1 TNDM t:slim X2's Compatibility With Lilly's Lyumjev Might Aid TNDM Stock
        Sep 30 NVO Novo Nordisk (NVO) Poised for 23.3% Upside as Obesity Market Expands and Clinical Trials Impress
        Sep 30 NVO Is Novo Nordisk A/S (NYSE:NVO) The Top Global Stock To Buy Now?
        Sep 29 NVO Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
        Sep 29 NVO 'Stop Ripping Us Off' – Incredibly, Elon Musk And Bernie Sanders Seem To Agree On This One Thing – 'I Really Am With Bernie On This One'
        Sep 28 NVO 15 Unhealthiest Countries in Europe
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Diabetes Endocrine System Hormones Insulin Pharmaceutical Products Pharmaceuticals Segment Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Caregiver Cough Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dietary Supplement Endocrinology Feminine Hygiene
        Diabetes Care

        Diabetes Care is a monthly peer-reviewed medical journal published since 1978 by the American Diabetes Association. The journal covers research in the following five categories: 1) clinical care/education/nutrition/psychosocial research, 2) epidemiology/health services research, 3) emerging treatments and technologies, 4) pathophysiology/complications, and 5) cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries.According to the Journal Citation Reports, the journal has a 2017 impact factor of 13.397 ranking it fifth out of 138 journals in the category "Endocrinology & Metabolism."

        More about Diabetes Care
        Browse All Tags